Ten things ICU specialists need to know about new valvular procedures in interventional cardiology
Every day, intensivists around the world are confronted with new and rapidly growing numbers of cardiac devices as part of an ever-evolving approach to treat heart diseases. Particularly noteworthy in this context are: one, transcatheter aortic valve replacement (TAVR); two, trans-septal procedures including transcatheter mitral valve repair (TMVR); and three, transcatheter tricuspid valve repair (TTVR). Different risk profiles of these procedures call for constant vigilance in terms of recognizing and reporting complications. There is a trend towards avoiding ICU admission for some of these patients, particularly for TAVR procedures, and the intensivist is likely to encounter complications in patients treated in the coronary care unit or onwards at various times post procedure. In this article, we outline ten important complications ICU specialists need to know related to these new procedures. Moreover, the extended heart team, which also includes the intensivist, can be an excellent...
There was no funding for this study.
Compliance with ethical standards
Conflicts of interest
Martin Orban has received speaker honoraria from SedanaMedical and AstraZeneca, outside the submitted work and the other authors have no conflicts of interest to declare.
All ethical standards were met in writing and submitting this correspondence.
- 1.Abdel-Wahab M, Comberg T, Buttner HJ et al (2014) Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience. JACC Cardiovasc Interv 7:284–292. https://doi.org/10.1016/j.jcin.2013.11.011 CrossRefPubMedGoogle Scholar
- 4.Barbanti M, Latib A, Sgroi C et al (2014) Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project. EuroIntervention 10:133–140. https://doi.org/10.4244/EIJV10I1A20 CrossRefPubMedGoogle Scholar
- 6.Eggebrecht H, Mehta RH, Kahlert P et al (2014) Emergent cardiac surgery during transcatheter aortic valve implantation (TAVR): insights from the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry. EuroIntervention 10:975–981. https://doi.org/10.4244/EIJV10I8A165 CrossRefPubMedGoogle Scholar
- 7.Eggebrecht H, Schelle S, Puls M et al (2015) Risk and outcomes of complications during and after MitraClip implantation: experience in 828 patients from the German TRAnscatheter mitral valve interventions (TRAMI) registry. Catheter Cardiovasc Interv 86:728–735. https://doi.org/10.1002/ccd.25838 CrossRefPubMedGoogle Scholar
- 9.Habib G, Lancellotti P, Antunes MJ et al (2015) 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36:3075–3128. https://doi.org/10.1093/eurheartj/ehv319 CrossRefPubMedGoogle Scholar
- 10.Khawaja MZ, Rajani R, Cook A et al (2011) Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve collaborative). Circulation 123:951–960. https://doi.org/10.1161/CIRCULATIONAHA.109.927152 CrossRefPubMedGoogle Scholar